Literature DB >> 24934791

Onco-nephrology: an invitation to a new field.

Kevin W Finkel1, Scott C Howard2.   

Abstract

Mesh：

Year:  2014        PMID： 24934791     DOI： 10.1200/JCO.2014.56.5622

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Paraprotein-Related Kidney Disease: Attack of the Killer M Proteins.

Authors:  Mark A Perazella; Kevin W Finkel
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-07       Impact factor: 8.237

Review 2.  Renal effects of targeted anticancer therapies.

Authors:  Camillo Porta; Laura Cosmai; Maurizio Gallieni; Paolo Pedrazzoli; Fabio Malberti
Journal:  Nat Rev Nephrol       Date:  2015-03-03       Impact factor: 28.314

Review 3.  Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy.

Authors:  Jennifer Dinnel; Bonny L Moore; Brent M Skiver; Prithviraj Bose
Journal:  Core Evid       Date:  2015-01-13

Review 4.  Considering renal risk while managing cancer.

Authors:  Vahakn B Shahinian; Amit Bahl; Daniela Niepel; Vito Lorusso
Journal:  Cancer Manag Res       Date:  2017-05-16       Impact factor: 3.989

Review 5.  Late renal toxicity of treatment for childhood malignancy: risk factors, long-term outcomes, and surveillance.

Authors:  Roderick Skinner
Journal:  Pediatr Nephrol       Date:  2017-04-22       Impact factor: 3.714
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.